Glyclopyramide

Glyclopyramide
Glyclopyramide
Systematic (IUPAC) name
4-chloro-N-[(pyrrolidin-1-ylamino)carbonyl]benzenesulfonamide
Clinical data
Pregnancy cat.  ?
Legal status ℞ Prescription only
Routes Oral
Identifiers
ATC code None
PubChem CID 71793
UNII KE474IKG1W YesY
KEGG D01799 YesY
Chemical data
Formula C11H14ClN3O3S 
Mol. mass 303.76 g/mol
SMILES eMolecules & PubChem
 YesY(what is this?)  (verify)

Glyclopyramide (INN, marketed under the tradename Deamelin-S) is a sulfonylurea drug used in the treatment of diabetes. It has been marketed in Japan since 1965.

It is classified as second generation.[1]

References

  1. ^ Ozawa H, Murai Y, Ozawa T (2003). "[A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus]" (in Japanese). Yakugaku Zasshi 38 (1): 11–27. PMID 14570054. 


v · d · eOral anti-diabetic drugs and Insulin analogs (A10)
Insulin
Metformin# • Buformin‡ • Phenformin‡
K+ ATP
Meglitinides/"glinides"
GLP-1 analogs
Exenatide • Liraglutide • Taspoglutide† • Albiglutide† • Lixisenatide
Analogs/other insulins
fast-acting (Insulin lispro • Insulin aspart • Insulin glulisine) • short-acting (Regular insulin) • long-acting (Insulin glargine • Insulin detemir • NPH insulin) • ultra-long-acting (Insulin degludec†) • inhalable Exubera‡
Other
Amylin analog
SGLT2 inhibitors
Canagliflozin† • Dapagliflozin† • Remogliflozin§ • Sergliflozin§
Other

M: END

anat/phys/devp/horm

noco(d)/cong/tumr, sysi/epon

proc, drug (A10/H1/H2/H3/H5)


Stub icon This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.